A novel fused delivery carrier Fc-Ii enhances mucosal and systemic immunity through the FcRn [PDF]
Fazhi Xu +3 more
openalex +1 more source
Case Report: Efgartigimod demonstrates significant clinical efficacy in double seropositive myasthenia gravis: a case report of a rare variant and analysis of pathomechanisms. [PDF]
Huang X, Wan Y, Chen Y, Lei K.
europepmc +1 more source
Structural Hijacking of FcRn by Human Astrovirus Spikes Reveals Conserved Epitopes for Broad-Spectrum Antivirals [PDF]
Sashank Agrawal +4 more
openalex +1 more source
A hybrid deep learning framework for skin disease localization and classification using wearable sensors. [PDF]
Zhao X, Zhang H, Zheng Q, Jing C.
europepmc +1 more source
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies. [PDF]
Brennan FR +29 more
europepmc +1 more source
Konformációváltozások kinetikájának modellezése elsőrendű reakcióhálózatokkal [PDF]
Tóbiás Roland József
core
Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end. [PDF]
Nilsen J +10 more
europepmc +1 more source
Intracellular interaction between FcRY receptor and IgY in ovarian vascular endothelial cells during avian maternal IgY transfer. [PDF]
Okamoto M +3 more
europepmc +1 more source
Translational population target binding model for the anti-FcRn fragment antibody efgartigimod
Sven Hoefman +4 more
openalex +1 more source

